Article Details
Retrieved on: 2025-01-07 19:44:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading afte.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here